Literature DB >> 15545103

Localisation and William Macewen's early brain surgery Part I: the controversy.

Malcolm Macmillan1.   

Abstract

Neurosurgery for the removal of brain tumours based on localising signs is usually dated from the 1884 operation by Bennett and Godlee. However, within weeks of that operation claims were made on behalf of William Macewen, the Glasgow surgeon, to have been the real pioneer of such surgery. According to Macewen's protagonists, he had conducted seven similar operations earlier than Bennett and Godlee and, in a notable 1888 address, Macewen described these seven pre-1884 cases and a number of others operated on after 1884. This paper, which is in two parts, contains an evaluation of the claims made for the priority of Macewen's pre-1884 operations. Part I deals mainly with Macewen's work in fields other than brain surgery that are relevant to it and sets out the facts of the controversy. It begins with a brief biography of Macewen, describes his pioneering work in antiseptic and aseptic surgery, his work on osteotomy and bone regeneration, and his use in brain surgery of the knowledge so gained. Part I concludes with an examination of the battle waged in the newspapers between Macewen's and Bennett's and Godlee's supporters, and of previously unpublished correspondence between Macewen himself, David Ferrier and Hughes Bennett. The primary records of the patients on whom Macewen operated, together with other materials relevant to the controversy, are examined in Part II.

Entities:  

Mesh:

Year:  2004        PMID: 15545103     DOI: 10.1080/09647040490881659

Source DB:  PubMed          Journal:  J Hist Neurosci        ISSN: 0964-704X            Impact factor:   0.529


  2 in total

1.  William Macewen [1848-1924].

Authors:  Malcolm Macmillan
Journal:  J Neurol       Date:  2010-03-20       Impact factor: 4.849

2.  The start and development of epilepsy surgery in Europe: a historical review.

Authors:  Olaf E M G Schijns; Govert Hoogland; Pieter L Kubben; Peter J Koehler
Journal:  Neurosurg Rev       Date:  2015-05-24       Impact factor: 3.042

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.